Skip to main content
. 2020 Jul 23;6:10. doi: 10.1186/s40959-020-00066-8

Table 2.

Changes in mean RV GLS, RV FAC and RV FWS at baseline to follow-up period from pre- to post-doxorubicin therapy at 6-month follow-up

N = 35 Pre Post P-value
LVEF (%) 63.3 ± 6.2 61.6 ± 11.1 0.37
RV GLS −22.4 ± 1.4 −20.6 ± 3.4 0.01
RV FAC (%) 47.3 ± 4.4 43.7 ± 3.9 0.01
RV FWS −24.9 ± 3.3 −22.2 ± 2.9 0.01

LVEF Left ventricular ejection fraction, RVFAC Right ventricular fractional area change, RVFWS Right ventricular free wall strain, RVGLS Right ventricular global longitudinal strain